Ophira Ginsburg has joined NYU Langone’s Perlmutter Cancer Center as director of its new High Risk Program, which identifies, studies and cares for patients with hereditary syndromes that increase cancer risk.
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
